A study showed that transcranial direct current stimulation (tDCS) on the primary motor cortex of ALS patients significantly improved global strength, reduced caregiver burden, enhanced quality of life scores, and decreased serum NF‐L levels [45]. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.